Abcam to participate in the Morgan Stanley 20th Annual Global Healthcare Conference

On September 1, 2022 Abcam plc (Nasdaq: ABCM; AIM: ABC) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, reported that Alan Hirzel, Chief Executive Officer, will be participating in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare conference at the Sheraton, New York Hotel in New York at approximately 4.10 p.m. BST (11.10 a.m. EDT) on 14 September 2022 (Press release, Abcam, SEP 1, 2022, View Source [SID1234618884]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the webcast, please use the following link:

View Source

The live audio webcast will also be available in the investor section of Abcam’s corporate website at corporate.abcam.com/investors/reports-presentations/. An archive will be available after the call at that same address.